文献速递血栓与止血

荷兰罕见出血性疾病女性产后出血高患病率:RBiN研究回顾性数据

High prevalence of postpartum hemorrhage in women with rare bleeding disorders in the Netherlands: retrospective data from the RBiN study.
PubMed 文献 · J Thromb Haemost · 2022-12-22

RBiN研究从荷兰全部6个血友病治疗中心纳入263例罕见出血性疾病患者,回顾性收集85例女性共244次妊娠(193次活产)的分娩、围产期止血预防及产后出血信息。产后出血总体报告率为44%(使用围产期止血预防的分娩)和53%(未使用者),未使用预防者产后失血量中位数1000 mL显著高于使用者400 mL(p=0.011);各病种产后出血率从凝血因子V缺乏的30%到纤溶亢进的100%。结论认为罕见凝血因子缺乏(无论严重或轻度)及纤溶障碍患者产后出血常见,尤其未给予围产期预防性止血治疗时,预防性止血治疗与较少产后失血相关。

要点

  • 85例罕见出血性疾病女性共报告244次妊娠、193次活产,产后出血总体常见。
  • 产后出血率从凝血因子V缺乏的30%到纤溶亢进的100%不等。
  • 未用围产期止血预防者产后失血中位数1000 mL,显著高于使用者400 mL(p=0.011)。

核心结论

  • 产后出血在罕见凝血因子缺乏(无论严重或轻度)及纤溶障碍患者中常见,尤其未给予围产期预防性止血治疗时。
  • 使用预防性止血治疗与较少的产后失血相关。

研究设计与样本

  • RBiN研究为回顾性研究,从荷兰全部6个血友病治疗中心纳入263例罕见出血性疾病患者。
  • 收集85例女性患者报告的244次妊娠(含193次活产)的分娩、围产期止血预防及产后出血信息,产后出血定义为失血量≥500 mL(世界卫生组织指南)。
  • 如可获得,从电子患者档案中提取产后失血精确容量。

主要发现

  • 85例女性报告244次妊娠(含193次活产),产后出血率从凝血因子V缺乏的30%到纤溶亢进的100%不等。
  • 使用围产期止血预防的分娩中产后出血报告率为44%,未使用者为53%。
  • 未使用止血预防的分娩产后失血量中位数1000 mL,显著高于使用预防的分娩中位数400 mL(p=0.011)。
  • 相对轻度的凝血因子缺乏患者在未给予围产期止血预防时也频繁发生产后出血。

关键数值与推荐

  • 产后出血定义为失血量≥500 mL(世界卫生组织指南)。
  • 产后出血率范围:凝血因子V缺乏30%至纤溶亢进100%。
  • 产后出血报告率:使用围产期止血预防的分娩44%,未使用者53%。
  • 产后失血量中位数:未使用止血预防1000 mL vs 使用预防400 mL(p=0.011)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Women with rare bleeding disorders (RBDs), including coagulation factor deficiencies and fibrinolytic disorders, may have a higher risk of postpartum hemorrhage (PPH). Information on this patient category is lacking in the existing PPH guidelines because data on PPH in patients with RBDs are scarce. OBJECTIVE: To describe the prevalence of PPH in women with an RBD and evaluate the use of peripartum hemostatic prophylaxis. METHODS: In the Rare Bleeding Disorders in the Netherlands (RBiN) study, patients with RBDs (n = 263) were included from all 6 Dutch hemophilia treatment centers. Patient-reported information on delivery, peripartum hemostatic prophylaxis, and occurrence of PPH was collected retrospectively. If available, information about the precise volume of postpartum blood loss was extracted from electronic patient files. PPH was defined as blood loss ≥500 mL (World Health Organization guideline). RESULTS: A total of 244 pregnancies, including 193 livebirths, were reported by 85 women. A considerable proportion of these women experienced PPH, ranging from 30% in factor V deficiency to 100% in hyperfibrinolysis. Overall, PPH was reported in 44% of deliveries performed with and 53% of deliveries performed without administration of peripartum hemostatic prophylaxis. Blood loss was significantly higher in deliveries without administration of hemostatic prophylaxis (median 1000 mL) compared to deliveries with administration of prophylaxis (median 400 mL) (p = 0.011). Patients with relatively mild deficiencies also frequently experienced PPH when peripartum hemostatic prophylaxis was omitted. CONCLUSION: PPH is common in rare coagulation factor deficiencies, both severe and mild, and fibrinolytic disorders, especially when peripartum prophylactic hemostatic treatment was not administered. The use of prophylactic hemostatic treatment was associated with less postpartum blood loss.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Maas DPMSM, Saes JL, Blijlevens NMA, et al. High prevalence of postpartum hemorrhage in women with rare bleeding disorders in the Netherlands: retrospective data from the RBiN study. J Thromb Haemost. 2022. PMID: 36696205. doi:10.1016/j.jtha.2022.11.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。